ArticleCancer discovery2022

Futibatinib, an Irreversible FGFR1-4 Inhibitor, in Patients with Advanced Solid Tumors Harboring

Funda Meric-Bernstam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.